Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-09-19
1999-07-13
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514249, 514259, 544235, 544285, 544286, 544287, 544288, 544289, 544290, 544291, 544292, 544293, 544353, 544354, 544356, C07D23972, C07D24140, A61K 31495, A61K 31505
Patent
active
059227117
ABSTRACT:
A compound of the formula: ##STR1## wherein --X.sup.3 .dbd.X.sup.2 --X.sup.1 .dbd.N-- is a group of the formula: ##STR2## R.sup.1 is hydrogen or halogen, R.sup.2 is halogen,
REFERENCES:
patent: 3682927 (1972-08-01), Carissimi et al.
patent: 4749406 (1988-06-01), Martin
patent: 5006534 (1991-04-01), Mohrs et al.
patent: 5212182 (1993-05-01), Musser et al.
patent: 5294622 (1994-03-01), Dreikorn et al.
patent: 5574042 (1996-11-01), Oku et al.
patent: 5750699 (1998-05-01), Oku et al.
Abe Yoshito
Inoue Takayuki
Kayakiri Hiroshi
Oku Teruo
Satoh Shigeki
Fujisawa Pharmaceutical Co. Ltd.
Grumbling Matthew V.
LandOfFree
8-substituted quinazolines, quinoxalines and benzopyridazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-substituted quinazolines, quinoxalines and benzopyridazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-substituted quinazolines, quinoxalines and benzopyridazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2275907